General Practitioners’ Prescribing Patterns at Primary Healthcare Centers in National Health Insurance, Gezira, Sudan

Busfield J. Assessing the overuse of medicines. Soc Sci Med. 2015;131:199–206. doi: 10.1016/j.socscimed.2014.10.061 .

Hogeriel HV, Bimo, Ross-Degnan D, et al. Field tests for rational drug use in twelve developing countries. Lancet. 1993;342(8884):1408–10.

Leung E, Weil DE, Raviglione M, Nakatani H. World Health Organization World Health Day Antimicrobial Resistance Technical Working Group. The WHO policy package to combat antimicrobial resistance. Bull World Health Organ. 2011;89(5):390–2.

Ganguly NK, Arora NK, Chandy SJ, Global Antibiotic Resistance Partnership (GARP)—India Working Group, et al. Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J Med Res. 2011;134(3):281–94.

World Health Organisation. How to investigate drug use in health facilities. WHO/DAP 93.1. Geneva: World Health Organization; 1993.

Dong L, Yan H, Wang D. Drug prescribing indicators in village health clinics across 10 provinces of Western China. Fam Pract. 2011;28(1):63–7.

Mustafa IEMA. The pattern of medicines use in Sudan: a crosssectional study at National Health Insurance Fund setting, in 2012. Swiss Tropical and Public Health Institute. tropEd Masters Programme in International Health. Geneva: WHO; 126.

Abdelmoneim IA, El-Tayeb IB, Omer ZB. Investigation of drug use in health centers in Khartoum state. Sudan Med J. 1999;37(2):21–6.

Elsalahi SH, Mudawi MME, Ahmed AAE. Evaluation of prescribing patterns in primary health care centres of Khartoum State, Sudan. Pharmanest. 2014;5(4):2242–7.

Cheraghali AM, Idries AM. Availability, affordability, and prescribing pattern of medicines in Sudan. Pharm World Sci. 2009;31(2):209–15.

Mahmoud RK, Kheder SI, Ali HM. Prescribing rationality in Khartoum state, Sudan: an update. Sudan Med Monitor. 2014;9(2):61.

Mahalli AAE. WHO/INRUD drug prescribing indicators at primary health care centres in Eastern province, Saudi Arabia. East Mediterr Health J. 2012;18(11):7.

Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63(2):187–95.

Yuxin Z, Mingguang Z. Index system and appraising method for comprehensive appraisal. J North Jiaotong Univ. 1995;19:393–400.

Bannenberg WJ, Forshaw CJ, Fresle D, Salami AO, Wahab HA, World Health Organization. Evaluation of the Nile province essential drugs project 1991. Geneva: WHO; 1991. p. 90.

Ali GEKFM. Management of revolving drug fund: experience of Khartoum State—Sudan. Bradford, UK; School of Pharmacy, University of Bradford: 2000.

Awad AI, Himad HA. Drug-use practices in teaching hospitals of Khartoum State, Sudan. Eur J Clin Pharmacol. 2006;62(12):1087–93.

Ahmed AM, Awad AI. Drug use practices at pediatric hospitals of Khartoum State, Sudan. Ann Pharmacother. 2010;44(12):1986–93.

Maiga D, Diawara A, Maiga MD. Evaluation of rational prescribing and dispensing of medicines in Mali. Rev Epidemiol Sante Publique. 2006;54(6):497–505.

Abdo-Rabbo A. Prescribing rationality and availability of antimalarial drugs in Hajjah, Yemen. East Mediterr Health J. 2003;9(4):607–17.

Ogwal-Okeng JW, Obua C, Waako P, Aupont O, Ross-Degnan D. A comparison of prescribing practices between public and private sector physicians in Uganda. East Afr Med J. 2004; Suppl:S12–6.

Pongsupap Y, Van Lerberghe W. Choosing between public and private or between hospital and primary care: responsiveness, patient-centredness and prescribing patterns in outpatient consultations in Bangkok. Trop Med Int Health. 2006;11(1):81–9.

Siddiqi S, Hamid S, Rafique G, Chaudhry SA, Ali N, Shahab S, Sauerborn R. Prescription practices of public and private health care providers in Attock District of Pakistan. Int J Health Plann Manage. 2002;17(1):23–40.

Patel V, Vaidya R, Naik D, Borker P. Irrational drug use in India: a prescription survey from Goa. J Postgrad Med. 2005;51(1):9–12.

Massele AY, Nsimba SE. Comparison of drug utilisation in public and private primary health care clinics in Tanzania. East Afr Med J. 1997;74(7):420–2.

Neyaz Y, Khoja T, Qureshi NA, Magzoub MA, Haycox A, Walley T. Medication prescribing pattern in primary care in Riyadh City, Saudi Arabia. East Mediterr Health J. 2011;17(2):149–55.

Tong SF, Khoo EM, Nordin S. Process of care and prescribing practices for hypertension in public and private primary care clinics in Malaysia. Asia Pac J Public Health. 2012;24(5):764–75.

Holloway KA, Ivanovska V, Wagner AK, Vialle-Valentin C, Ross-Degnan D. Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence. Trop Med Int Health. 2013;18(6):656–64.

Naseeb TA, Nasser MA. Drug prescribing indicators in primary health care centers in Bahrain. Saudi Med J. 2005;26(9):1436–8.

Otoom S, Batieha A, Hadidi H, Hasan M, Al-Saudi K. Evaluation of drug use in Jordan using WHO prescribing indicators. East Mediterr Health J. 2002;8(4–5):537–43.

Akl OA, El Mahalii AA, Elkahky AA, Salem AM. WHO/INRUD drug use indicators at primary healthcare centers in Alexandria, Egypt. J Taibah Univ Med Sci. 2014;9(1):54–64.